000 01238 a2200361 4500
005 20250516145512.0
264 0 _c20130919
008 201309s 0 0 eng d
022 _a1742-4690
024 7 _a10.1186/1742-4690-10-46
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFricke, Thomas
245 0 0 _aThe ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6.
_h[electronic resource]
260 _bRetrovirology
_cApr 2013
300 _a46 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aCell Line
650 0 4 _aHIV-1
_ximmunology
650 0 4 _aHumans
650 0 4 _aReverse Transcription
650 0 4 _aVirus Integration
650 0 4 _abeta Karyopherins
_xmetabolism
650 0 4 _amRNA Cleavage and Polyadenylation Factors
_xmetabolism
700 1 _aValle-Casuso, Jose Carlos
700 1 _aWhite, Tommy E
700 1 _aBrandariz-Nuñez, Alberto
700 1 _aBosche, William J
700 1 _aReszka, Natalia
700 1 _aGorelick, Robert
700 1 _aDiaz-Griffero, Felipe
773 0 _tRetrovirology
_gvol. 10
_gp. 46
856 4 0 _uhttps://doi.org/10.1186/1742-4690-10-46
_zAvailable from publisher's website
999 _c22703937
_d22703937